Changing Faces – Digital and supplier hires – August and Sep...
There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.
MSD, Eisai abandon combination trial in liver cancer
MSD and Eisai's oncology partnership has had mixed fortunes this week, with a disappointment in liver cancer and encouraging data in kidney cancer.
BridgeBio two for two as rare disease drug aces ph3 trial
BridgeBio's week just went from great to superb, as it reports a second positive topline result in a pivotal trial of a late-stage pipeline drug.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Citius Oncology Signs Exclusive Commercialization Agreement ...
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
7th Annual AI in Drug Discovery Conference
The 7th Annual AI in Drug Discovery Conference, hosted by SAE Media Group, takes place in March 2026
6th Age-Related Disease Therapeutics Summit
Translating Aging Science into a Clinical Reality
7th CNS Drug Delivery Summit
Unlocking Safer, More Efficient Delivery to Targeted Brain Regions by Advancing Direct, & Systemic Delivery to the CNS Via TfR1 & Beyond
Targeted Therapies Partnering & Licensing Summit Asia
Accelerate Licensing & Co-Development in Asia: Providing Pharma De-Risked Assets to Fuel Pipelines Faster, & Biotech Access to International Partnersh